{
    "2020-04-06": [
        [
            {
                "time": "",
                "original_text": "白雲山（0874.HK）：「混改+分拆上市」双重加持，投資機會顯現？",
                "features": {
                    "keywords": [
                        "白雲山",
                        "混改",
                        "分拆上市",
                        "投資機會"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "醫藥",
                        "中成藥"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "百億中藥企業交卷，白雲山、雲南白藥、同仁堂、華潤三九哪家強？",
                "features": {
                    "keywords": [
                        "白雲山",
                        "雲南白藥",
                        "同仁堂",
                        "華潤三九",
                        "中藥企業"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "醫藥",
                        "中成藥"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}